The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.60
Bid: 69.20
Ask: 69.40
Change: 0.00 (0.00%)
Spread: 0.20 (0.289%)
Open: 68.60
High: 0.00
Low: 0.00
Prev. Close: 68.60
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

15 Mar 2024 11:59

RNS Number : 0526H
Coca-Cola Europacific Partners plc
15 March 2024
 

COCA-COLA EUROPACIFIC PARTNERS PLC FILES INTEGRATED REPORT AND FORM 20-F

LONDON, 15 March 2024 - Coca-Cola Europacific Partners plc ("CCEP") (ticker symbol CCEP) announces that, on 15 March 2024, it filed its 2023 Integrated Report and Form 20-F with the Securities and Exchange Commission. This document was filed in accordance with Rule 5250(d) of the Nasdaq Listing Rules and includes CCEP's audited results for the year ended 31 December 2023. The unaudited fourth-quarter and full year results for the period ended 31 December 2023 were released on 23 February 2024.

The 2023 Integrated Report and Form 20-F is available on CCEP's website at https://ir.cocacolaep.com/financial-reports-and-results/integrated-reports and also online at www.sec.gov

A copy of the 2023 Integrated Report and Form 20-F will be available shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

In accordance with Disclosure Guidance and Transparency Rules 4.1 and 6.3.5(1A), the regulated information required under DTR 6.3.5 is available in unedited full text within the 2023 Integrated Report as uploaded and available on the National Storage Mechanism and on the Company's website as noted above.

 

CONTACTS

Company Secretariat

Clare Wardle

T +44 20 7355 8406

Investor Relations

Sarah Willett

+44 7970 145 218

Media Relations

Shanna Wendt

T +44 7976 595 168

 

ABOUT CCEP

CCEP is one of the leading consumer goods companies in the world. We make, move and sell some the world's most loved brands - serving 600 million consumers and helping more than 2 million customers across 31 countries grow. We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support. The Company is currently listed on Euronext Amsterdam, NASDAQ (and a constituent of the Nasdaq 100), London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on LinkedIn @Coca-Cola Europacific Partners | LinkedIn

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSEANDSFANLEEA
Date   Source Headline
20th Jul 20224:30 pmRNSDirector/PDMR Shareholding
14th Jul 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:30 pmRNSDirector/PDMR Shareholding
9th Jun 202212:00 pmRNSDirector/PDMR Shareholding
1st Jun 20223:10 pmRNSTotal Voting Rights
27th May 20223:30 pmRNSResult of AGM
24th May 20223:30 pmRNSDirector/PDMR Shareholding
16th May 202212:00 pmRNSLetter to Shareholders
3rd May 20222:40 pmRNSTotal Voting Rights
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSQ1 2022 Trading Update
21st Apr 20225:20 pmRNSDirector/PDMR Shareholding
14th Apr 20229:00 amRNSNotice of AGM
23rd Mar 20221:50 pmRNSDirector/PDMR Shareholding
18th Mar 20222:15 pmRNSBlock listing Interim Review
17th Mar 20225:30 pmRNSDirector/PDMR Shareholding
15th Mar 20226:11 pmRNSAnnual Financial Report
14th Mar 20226:30 pmRNSDirector/PDMR Shareholding
10th Mar 20226:00 pmRNSDirector/PDMR Shareholding
9th Mar 20229:06 amRNSDirector/PDMR Shareholding
8th Mar 20224:00 pmRNSDirector/PDMR Shareholding
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 20222:00 pmRNSTotal Voting Rights
28th Feb 20225:30 pmRNSDirector/PDMR Shareholding
23rd Feb 20225:30 pmRNSDirector/PDMR Shareholding
16th Feb 20224:35 pmRNSPrice Monitoring Extension
16th Feb 20227:00 amRNSPreliminary Unaudited Results Q4 & FY 2021
1st Feb 20221:30 pmRNSTotal Voting Rights
24th Jan 20223:00 pmRNSDirector/PDMR Shareholding
4th Jan 202212:45 pmRNSTotal Voting Rights
21st Dec 20213:45 pmRNSDirector/PDMR Shareholding
16th Dec 20211:45 pmRNSDirector/PDMR Shareholding
1st Dec 20212:45 pmRNSTotal Voting Rights
23rd Nov 20213:15 pmRNSDirector/PDMR Shareholding
17th Nov 20214:35 pmRNSPrice Monitoring Extension
9th Nov 20217:00 amRNSQ3 Trading Update & FY21 Dividend Declaration
1st Nov 20212:30 pmRNSTotal Voting Rights
25th Oct 20214:41 pmRNSSecond Price Monitoring Extn
25th Oct 20214:36 pmRNSPrice Monitoring Extension
21st Oct 20214:41 pmRNSSecond Price Monitoring Extn
21st Oct 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20214:40 pmRNSSecond Price Monitoring Extn
20th Oct 20214:35 pmRNSPrice Monitoring Extension
20th Oct 20214:30 pmRNSDirector/PDMR Shareholding
15th Oct 20214:41 pmRNSSecond Price Monitoring Extn
15th Oct 20214:36 pmRNSPrice Monitoring Extension
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20212:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.